Everest Medicines’ Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery

Everest Medicines’ Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery

HONG KONG, Oct 18, 2024 – (ACN Newswire) – Everest Medicines (1952.HK) closed today with a 20.46% increase, hitting a high of HKD 28.6. The company’s stock price has been steadily rising since the release of its interim results, with today’s trading volume reaching HKD 291 million…
Read More

Zaļā Josta - Reklāma